![Christophe Berthoux](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Christophe Berthoux
No open positions remaining
Profile
Christophe Berthoux is Chief Executive Officer at Resonant Clinical Solutions, Inc. since 2025.
Chairman at Image Analysis Ltd. since 2018.
Director at Future Meds Ltd. since 2020.
Operating Partner at ArchiMed SAS since 2019.
Former Chief Executive Officer at Synexus Clinical Research Ltd. Former Chief Executive Officer at North American Science Associates LLC.
Former Director at genOway SA. Former Chief Commercial Officer & EVP-Global Sales at Charles River Laboratories Edinburgh Ltd. Education includes a doctorate from the University of Pennsylvania and graduate studies at Purdue University.
Christophe Berthoux active positions
| Companies | Position | Start |
|---|---|---|
Image Analysis Ltd.
 Image Analysis Ltd. Internet Software/ServicesTechnology Services Operates a cloud-based platform that provides medical imaging services and analytical software | Chairman | 2018-10-01 |
ArchiMed SAS
 ArchiMed SAS Investment ManagersFinance ArchiMed invests in small and middle-sized companies located across the globe. The firm targets companies operating in the field of the healthcare sector. It participates in growth and buyout transactions with an investment size of EUR 10 - 1000 million. The firm makes follow-on investments. | Private Equity Investor | 2019-08-31 |
Future Meds Ltd.
 Future Meds Ltd. Miscellaneous Commercial ServicesCommercial Services Operates research sites which provides patient recruitment and clinical trial management services | Director/Board Member | - |
Former positions of Christophe Berthoux
| Companies | Position | End |
|---|---|---|
North American Science Associates LLC
 North American Science Associates LLC Miscellaneous Commercial ServicesCommercial Services Provides medical device testing, preclinical and clinical research & regulatory compliance consulting services | Chief Executive Officer | - |
Charles River Laboratories Edinburgh Ltd.
 Charles River Laboratories Edinburgh Ltd. Pharmaceuticals: MajorHealth Technology Provides scientific research services | Sales & Marketing | - |
| GENOWAY | Director/Board Member | - |
Synexus Clinical Research Ltd.
 Synexus Clinical Research Ltd. Medical/Nursing ServicesHealth Services Offers clinical trials and biological research services | Chief Executive Officer | - |
Training of Christophe Berthoux
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
52
1st degree connections
9
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 9 |
|---|---|
Synexus Clinical Research Ltd.
Synexus Clinical Research Ltd. Medical/Nursing ServicesHealth Services Offers clinical trials and biological research services | Health Services |
University of Pennsylvania
 University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Charles River Laboratories Edinburgh Ltd.
Charles River Laboratories Edinburgh Ltd. Pharmaceuticals: MajorHealth Technology Provides scientific research services | Health Technology |
genOway SA
 genOway SA BiotechnologyHealth Technology Develops gene technology | Health Technology |
Purdue University
 Purdue University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
North American Science Associates LLC
North American Science Associates LLC Miscellaneous Commercial ServicesCommercial Services Provides medical device testing, preclinical and clinical research & regulatory compliance consulting services | Commercial Services |
ArchiMed SAS
ArchiMed SAS Investment ManagersFinance ArchiMed invests in small and middle-sized companies located across the globe. The firm targets companies operating in the field of the healthcare sector. It participates in growth and buyout transactions with an investment size of EUR 10 - 1000 million. The firm makes follow-on investments. | Finance |
Image Analysis Ltd.
Image Analysis Ltd. Internet Software/ServicesTechnology Services Operates a cloud-based platform that provides medical imaging services and analytical software | Technology Services |
Future Meds Ltd.
Future Meds Ltd. Miscellaneous Commercial ServicesCommercial Services Operates research sites which provides patient recruitment and clinical trial management services | Commercial Services |
- Stock Market
- Insiders
- Christophe Berthoux
